Archive · 20 Jul 2025
RSV Vaccine Reduces Newborn Hospitalization Rates in UK
A new vaccine given to pregnant women is helping to protect babies from a serious lung infection called RSV.
This vaccine was introduced in the UK in the summer of 2024.
Researchers found that when mothers got the vaccine, there were 72% fewer babies who needed to go to the hospital with the infection.
RSV is a common virus that causes colds but can be dangerous for babies.
Doctors suggest getting the vaccine during pregnancy, ideally after 28 weeks, to give the baby the best protection.
A new RSV vaccine for pregnant women linked to a drop in newborn hospitalizations.
The vaccine was introduced in the UK in late summer 2024.
Researchers found a 72% reduction in hospitalizations for babies whose mothers were vaccinated.
RSV is a common virus that can lead to severe lung infections in babies.
Experts recommend vaccination from 28 weeks of pregnancy for optimal protection.
- Who
- Researchers at the Universities of Edinburgh and Leicester.
- What
- A new RSV vaccine for pregnant women linked to a drop in newborn hospitalizations.
- When
- Introduced in the UK in late summer 2024.
- Where
- UK
- Why
- To reduce the number of babies hospitalized with RSV.
- Vaccine Target
- Pregnant Women
- Vaccine Introduced
- Late Summer 2024
- Reduction in Hospitalization
- 72%
- Virus
- RSV (Respiratory Syncytial Virus)
- Study Location
- England and Scotland